Pfizer's Weight-Loss Data Just Upends Investor Bets
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
A single index chart move often signals momentum shifts; understanding its implications helps traders frame positions and adapt risk controls.
26,274 articlesPfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Tech shares rebound as AI demand supports earnings. This report highlights the best tech stocks right now, detailing ...
Investors bias portfolios by political leanings, potentially hurting gains. Experts say open dialogue across camps ca...
Meta Platforms paused the public rollout of its Avocado AI model to focus on quality, while expanding its Hyperion da...
A new five-pillar framework unveiled by a top U.S. official signals a hard turn toward reshoring, tougher trade terms...
A quartet of high-yield international ETFs has posted stronger returns than the S&P 500 over the past year, deliverin...
A social-media frenzy around trillionaire wealth centers on Elon Musk, sparking a debate about how market values, pri...
Microsoft stock slid about 25% in Q1 2026, its worst showing in years, as AI spending accelerates yet revenue signals...
For 155 years, one benchmark on Wall Street has loomed as nearly invincible. Now signs are emerging that this longsta...
As of May 7, 2026, Trump’s drug-pricing drive shows a mixed outcome: some medicines price cuts, but many others highe...
A focused infrastructure fund rode the AI build-out to roughly 28% gains through mid-2026, underscoring how concentra...
Market chatter about a SpaceX mega-IPO is heating up, but the professor tracks every just IPO, warning that lofty val...